StockNews.com Begins Coverage on Atrion (NASDAQ:ATRI)

StockNews.com initiated coverage on shares of Atrion (NASDAQ:ATRI – Get Rating) in a research note published on Thursday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock.

Atrion Trading Up 1.0 %

Shares of Atrion stock opened at $607.00 on Thursday. The company has a 50 day moving average of $645.60 and a 200-day moving average of $614.57. Atrion has a 1-year low of $534.99 and a 1-year high of $766.72. The company has a market cap of $1.07 billion, a PE ratio of 31.05 and a beta of 0.44.

Atrion Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 31st. Stockholders of record on Wednesday, March 15th will be issued a dividend of $2.15 per share. This represents a $8.60 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Tuesday, March 14th. Atrion’s dividend payout ratio (DPR) is presently 43.99%.

Institutional Trading of Atrion

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Goldman Sachs Group Inc. lifted its holdings in shares of Atrion by 0.8% during the 2nd quarter. Goldman Sachs Group Inc. now owns 1,929 shares of the medical instruments supplier’s stock worth $1,213,000 after acquiring an additional 16 shares during the period. Pathstone Family Office LLC lifted its holdings in shares of Atrion by 2.2% during the 4th quarter. Pathstone Family Office LLC now owns 920 shares of the medical instruments supplier’s stock worth $517,000 after acquiring an additional 20 shares during the period. Roberts Glore & Co. Inc. IL lifted its stake in Atrion by 0.3% in the 3rd quarter. Roberts Glore & Co. Inc. IL now owns 6,058 shares of the medical instruments supplier’s stock valued at $3,423,000 after purchasing an additional 21 shares during the last quarter. ICW Investment Advisors LLC lifted its stake in Atrion by 1.0% in the 3rd quarter. ICW Investment Advisors LLC now owns 2,412 shares of the medical instruments supplier’s stock valued at $1,363,000 after purchasing an additional 24 shares during the last quarter. Finally, Harbor Investment Advisory LLC lifted its stake in Atrion by 26.7% in the 4th quarter. Harbor Investment Advisory LLC now owns 114 shares of the medical instruments supplier’s stock valued at $64,000 after purchasing an additional 24 shares during the last quarter. Institutional investors own 64.90% of the company’s stock.

Atrion Company Profile

(Get Rating)

Atrion Corp. engages in the manufacture and development of products for medical applications. It offers products for cardiovascular, fluid delivery, and ophthalmic. It also offers contract manufacturing and kitting services, and marine & aviation inflation components. The company was founded in 1944 and is headquartered in Allen, TX.